Development of cutaneous squamous cell carcinoma during pembrolizumab therapy
Gespeichert in:
| Veröffentlicht in: | Journal of dermatology 2021-01, Vol.48 (1), p.e7-e8 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e8 |
|---|---|
| container_issue | 1 |
| container_start_page | e7 |
| container_title | Journal of dermatology |
| container_volume | 48 |
| creator | Mizutani, Kento Nakanishi, Takehisa Ikejiri, Makoto Yuasa, Hiroto Matsushima, Yoshiaki Kondo, Makoto Nakai, Yasuo Habe, Koji Nakatani, Kaname Yamanaka, Keiichi |
| description | |
| doi_str_mv | 10.1111/1346-8138.15614 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_32940367</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2443879585</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3954-735596a18f4aaa1ea3081885b4e999c197d864075b9cbb11d344c64f9c095a2a3</originalsourceid><addsrcrecordid>eNqNkE1P3DAURS1UVAbaNTsUqRskFLBjO7GXaPgWFZt2bTmel9YoiYMdg4Zfj0Oms2BDvfGTde7T8UXokOBTks4ZoazMBaHilPCSsB202L58QQtMBc8Lhqs9tB_CI8aF5AR_RXu0kAzTslqgnxfwDK0bOujHzDWZiaPuwcWQhaeou2kw0LaZ0d7Y3nU6W0Vv-z_ZAF3tXWtfY6frbPwLXg_rb2i30W2A75v7AP2-uvy1vMnvH65vl-f3uaGSs7yinMtSE9EwrTUBTbEgQvCagZTSEFmtRJm0eS1NXROyooyZkjXSYMl1oekBOp73Dt49RQij6myYPGd3VTBGRSW54An98QF9dNH3yS5RFatKJmWVqLOZMt6F4KFRg7ed9mtFsJqaVlOvaupVvTedEkebvbHuYLXl_1WbADEDL1C7JhgLvYEthjHmpRQUyzRhsrSjHq3rly72Y4qe_H800XxD2xbWn4mru4vL-Qdv1u2n3A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2474764997</pqid></control><display><type>article</type><title>Development of cutaneous squamous cell carcinoma during pembrolizumab therapy</title><source>MEDLINE</source><source>Web of Science - Science Citation Index Expanded - 2021<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /></source><source>Wiley Online Library All Journals</source><creator>Mizutani, Kento ; Nakanishi, Takehisa ; Ikejiri, Makoto ; Yuasa, Hiroto ; Matsushima, Yoshiaki ; Kondo, Makoto ; Nakai, Yasuo ; Habe, Koji ; Nakatani, Kaname ; Yamanaka, Keiichi</creator><creatorcontrib>Mizutani, Kento ; Nakanishi, Takehisa ; Ikejiri, Makoto ; Yuasa, Hiroto ; Matsushima, Yoshiaki ; Kondo, Makoto ; Nakai, Yasuo ; Habe, Koji ; Nakatani, Kaname ; Yamanaka, Keiichi</creatorcontrib><identifier>ISSN: 0385-2407</identifier><identifier>EISSN: 1346-8138</identifier><identifier>DOI: 10.1111/1346-8138.15614</identifier><identifier>PMID: 32940367</identifier><language>eng</language><publisher>HOBOKEN: Wiley</publisher><subject>Antibodies, Monoclonal, Humanized - adverse effects ; Carcinoma, Squamous Cell - chemically induced ; Carcinoma, Squamous Cell - drug therapy ; Dermatology ; Humans ; Life Sciences & Biomedicine ; Monoclonal antibodies ; Pembrolizumab ; Science & Technology ; Skin Neoplasms - chemically induced ; Skin Neoplasms - drug therapy ; Squamous cell carcinoma ; Squamous Cell Carcinoma of Head and Neck</subject><ispartof>Journal of dermatology, 2021-01, Vol.48 (1), p.e7-e8</ispartof><rights>2020 Japanese Dermatological Association</rights><rights>Copyright © 2021 Japanese Dermatological Association</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>1</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000569830900001</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c3954-735596a18f4aaa1ea3081885b4e999c197d864075b9cbb11d344c64f9c095a2a3</citedby><cites>FETCH-LOGICAL-c3954-735596a18f4aaa1ea3081885b4e999c197d864075b9cbb11d344c64f9c095a2a3</cites><orcidid>0000-0001-5171-4909 ; 0000-0003-3055-5202</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2F1346-8138.15614$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2F1346-8138.15614$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,27929,27930,39263,45579,45580</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32940367$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mizutani, Kento</creatorcontrib><creatorcontrib>Nakanishi, Takehisa</creatorcontrib><creatorcontrib>Ikejiri, Makoto</creatorcontrib><creatorcontrib>Yuasa, Hiroto</creatorcontrib><creatorcontrib>Matsushima, Yoshiaki</creatorcontrib><creatorcontrib>Kondo, Makoto</creatorcontrib><creatorcontrib>Nakai, Yasuo</creatorcontrib><creatorcontrib>Habe, Koji</creatorcontrib><creatorcontrib>Nakatani, Kaname</creatorcontrib><creatorcontrib>Yamanaka, Keiichi</creatorcontrib><title>Development of cutaneous squamous cell carcinoma during pembrolizumab therapy</title><title>Journal of dermatology</title><addtitle>J DERMATOL</addtitle><addtitle>J Dermatol</addtitle><subject>Antibodies, Monoclonal, Humanized - adverse effects</subject><subject>Carcinoma, Squamous Cell - chemically induced</subject><subject>Carcinoma, Squamous Cell - drug therapy</subject><subject>Dermatology</subject><subject>Humans</subject><subject>Life Sciences & Biomedicine</subject><subject>Monoclonal antibodies</subject><subject>Pembrolizumab</subject><subject>Science & Technology</subject><subject>Skin Neoplasms - chemically induced</subject><subject>Skin Neoplasms - drug therapy</subject><subject>Squamous cell carcinoma</subject><subject>Squamous Cell Carcinoma of Head and Neck</subject><issn>0385-2407</issn><issn>1346-8138</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>HGBXW</sourceid><sourceid>EIF</sourceid><recordid>eNqNkE1P3DAURS1UVAbaNTsUqRskFLBjO7GXaPgWFZt2bTmel9YoiYMdg4Zfj0Oms2BDvfGTde7T8UXokOBTks4ZoazMBaHilPCSsB202L58QQtMBc8Lhqs9tB_CI8aF5AR_RXu0kAzTslqgnxfwDK0bOujHzDWZiaPuwcWQhaeou2kw0LaZ0d7Y3nU6W0Vv-z_ZAF3tXWtfY6frbPwLXg_rb2i30W2A75v7AP2-uvy1vMnvH65vl-f3uaGSs7yinMtSE9EwrTUBTbEgQvCagZTSEFmtRJm0eS1NXROyooyZkjXSYMl1oekBOp73Dt49RQij6myYPGd3VTBGRSW54An98QF9dNH3yS5RFatKJmWVqLOZMt6F4KFRg7ed9mtFsJqaVlOvaupVvTedEkebvbHuYLXl_1WbADEDL1C7JhgLvYEthjHmpRQUyzRhsrSjHq3rly72Y4qe_H800XxD2xbWn4mru4vL-Qdv1u2n3A</recordid><startdate>202101</startdate><enddate>202101</enddate><creator>Mizutani, Kento</creator><creator>Nakanishi, Takehisa</creator><creator>Ikejiri, Makoto</creator><creator>Yuasa, Hiroto</creator><creator>Matsushima, Yoshiaki</creator><creator>Kondo, Makoto</creator><creator>Nakai, Yasuo</creator><creator>Habe, Koji</creator><creator>Nakatani, Kaname</creator><creator>Yamanaka, Keiichi</creator><general>Wiley</general><general>Wiley Subscription Services, Inc</general><scope>BLEPL</scope><scope>DTL</scope><scope>HGBXW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5171-4909</orcidid><orcidid>https://orcid.org/0000-0003-3055-5202</orcidid></search><sort><creationdate>202101</creationdate><title>Development of cutaneous squamous cell carcinoma during pembrolizumab therapy</title><author>Mizutani, Kento ; Nakanishi, Takehisa ; Ikejiri, Makoto ; Yuasa, Hiroto ; Matsushima, Yoshiaki ; Kondo, Makoto ; Nakai, Yasuo ; Habe, Koji ; Nakatani, Kaname ; Yamanaka, Keiichi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3954-735596a18f4aaa1ea3081885b4e999c197d864075b9cbb11d344c64f9c095a2a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Antibodies, Monoclonal, Humanized - adverse effects</topic><topic>Carcinoma, Squamous Cell - chemically induced</topic><topic>Carcinoma, Squamous Cell - drug therapy</topic><topic>Dermatology</topic><topic>Humans</topic><topic>Life Sciences & Biomedicine</topic><topic>Monoclonal antibodies</topic><topic>Pembrolizumab</topic><topic>Science & Technology</topic><topic>Skin Neoplasms - chemically induced</topic><topic>Skin Neoplasms - drug therapy</topic><topic>Squamous cell carcinoma</topic><topic>Squamous Cell Carcinoma of Head and Neck</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mizutani, Kento</creatorcontrib><creatorcontrib>Nakanishi, Takehisa</creatorcontrib><creatorcontrib>Ikejiri, Makoto</creatorcontrib><creatorcontrib>Yuasa, Hiroto</creatorcontrib><creatorcontrib>Matsushima, Yoshiaki</creatorcontrib><creatorcontrib>Kondo, Makoto</creatorcontrib><creatorcontrib>Nakai, Yasuo</creatorcontrib><creatorcontrib>Habe, Koji</creatorcontrib><creatorcontrib>Nakatani, Kaname</creatorcontrib><creatorcontrib>Yamanaka, Keiichi</creatorcontrib><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Web of Science - Science Citation Index Expanded - 2021</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mizutani, Kento</au><au>Nakanishi, Takehisa</au><au>Ikejiri, Makoto</au><au>Yuasa, Hiroto</au><au>Matsushima, Yoshiaki</au><au>Kondo, Makoto</au><au>Nakai, Yasuo</au><au>Habe, Koji</au><au>Nakatani, Kaname</au><au>Yamanaka, Keiichi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development of cutaneous squamous cell carcinoma during pembrolizumab therapy</atitle><jtitle>Journal of dermatology</jtitle><stitle>J DERMATOL</stitle><addtitle>J Dermatol</addtitle><date>2021-01</date><risdate>2021</risdate><volume>48</volume><issue>1</issue><spage>e7</spage><epage>e8</epage><pages>e7-e8</pages><issn>0385-2407</issn><eissn>1346-8138</eissn><cop>HOBOKEN</cop><pub>Wiley</pub><pmid>32940367</pmid><doi>10.1111/1346-8138.15614</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0001-5171-4909</orcidid><orcidid>https://orcid.org/0000-0003-3055-5202</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0385-2407 |
| ispartof | Journal of dermatology, 2021-01, Vol.48 (1), p.e7-e8 |
| issn | 0385-2407 1346-8138 |
| language | eng |
| recordid | cdi_pubmed_primary_32940367 |
| source | MEDLINE; Web of Science - Science Citation Index Expanded - 2021<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" />; Wiley Online Library All Journals |
| subjects | Antibodies, Monoclonal, Humanized - adverse effects Carcinoma, Squamous Cell - chemically induced Carcinoma, Squamous Cell - drug therapy Dermatology Humans Life Sciences & Biomedicine Monoclonal antibodies Pembrolizumab Science & Technology Skin Neoplasms - chemically induced Skin Neoplasms - drug therapy Squamous cell carcinoma Squamous Cell Carcinoma of Head and Neck |
| title | Development of cutaneous squamous cell carcinoma during pembrolizumab therapy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T16%3A45%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20of%20cutaneous%20squamous%20cell%20carcinoma%20during%20pembrolizumab%20therapy&rft.jtitle=Journal%20of%20dermatology&rft.au=Mizutani,%20Kento&rft.date=2021-01&rft.volume=48&rft.issue=1&rft.spage=e7&rft.epage=e8&rft.pages=e7-e8&rft.issn=0385-2407&rft.eissn=1346-8138&rft_id=info:doi/10.1111/1346-8138.15614&rft_dat=%3Cproquest_pubme%3E2443879585%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2474764997&rft_id=info:pmid/32940367&rfr_iscdi=true |